Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1071 | 983 | 1240 | 1179 | 1324 | 1587 |
Fund Return | 7.1% | -1.66% | 24.03% | 5.64% | 5.78% | 4.73% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LVIP SSgA SP 500 Index Fund Standar | 8.65B | 21.88 | 11.66 | 13.12 | ||
LVIP SSgA SP 500 Index Fund Service | 2.71B | 21.64 | 11.38 | 12.83 | ||
LVIP American Growth Fund Service I | 2.35B | 22.75 | 5.31 | 15.56 | ||
LVIP SSgA Large Cap 100 Fund Class | 1.47B | 23.25 | 10.99 | 11.09 | ||
Lincoln Variable Insurance Products | 1.09B | 17.55 | 6.78 | 8.62 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox International Stock | 39.84B | 8.75 | 5.16 | 4.54 | ||
Fidelity Series International VVV | 14.98B | 10.37 | 7.59 | 5.74 | ||
Vanguard International Value Inv | 12.95B | 4.98 | 2.27 | 4.43 | ||
Causeway International Value Instl | 10.3B | 6.85 | 8.13 | 5.56 | ||
DFA International Value I | 8.88B | 9.09 | 7.07 | 5.42 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.35 | 750.9 | +4.03% | |
Novartis | CH0012005267 | 1.74 | 93.68 | +2.32% | |
ASML Holding | NL0010273215 | 1.56 | 642.10 | +1.68% | |
Unilever | GB00B10RZP78 | 1.51 | 56.44 | +3.45% | |
BHP Group Ltd | AU000000BHP4 | 1.42 | 40.200 | +0.10% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review